The idea of US crude being a shelter from turmoil abroad may not be as far fetched as it seems.
VIDEO ON MSN MONEY
The stock has usually traded on subscriber growth and we expect international expansion to generate positive news flow this year.
Netflix primarily competes with streaming services such as those by Amazon Amazon (AMZN) and Dish Network's (DISH) Blockbuster, as well as DVD rental companies such as Redbox.
Stricter lending requirements have led to a marked improvement in the bank's credit quality.
We have revisited our analysis of Capital One (COF) in light of economic conditions and the company's performance. Capital One is the fifth largest bank in the U.S. and competes with American Express (AXP), Discover Financial (DFS), Bank of America (BAC) and JPMorgan Chase (JPM).
In October, Capital One reported a strong third quarter net income of $865 million, which was up 5.7% from the same period in the prior year, but down 8.5% from the prior quarter (we've excluded income from discontinued operations in our analysis). Our updated price estimate for Capital One of $48 is about 5% ahead of the current market price.
They may look cheap, but don’t let that fool you.
By Sean Williams
Well, here we are yet again, folks. With Alcoa reporting quarterly results earlier this week, earnings season is officially upon us, which can mean only one thing: Volatility is about to rear its ugly face once again.
I took some time last week to scour the tech sector in the hopes of finding some potential winners and losers for the first-quarter of 2012. What I found was a disturbing number of potential losers. So without further ado, I give you three tech names that I'm not going near this earnings season.
Investors earning next to nothing in cash have many choices when looking for better returns.
This post is one in a series in which more than 50 newsletter advisers share their Top Picks for 2012.
By Jack Bowers, Fidelity Monitor
What are the best income funds for 2012? Following are the Fidelity funds we think are well-positioned for the year, listed in increasing order of risk.
General Motors is upgraded to 'overweight.'
Wednesday's noteworthy upgrades include:
Trying to find a stock I like simply because the S&P 500 is breaking out just isn’t my style.
The S&P 500 ($INX) has hit the levels that everyone can call breakout at the exact same time that I am struggling to find stocks to buy.
I know that sounds counterintuitive, but here's the deal. In an ETF-dominated world, the technicians rule. If the fundamentals mattered, you wouldn't want to own the ETF, you would want to own the best of breed in the sector. But if the technicals are in charge, you just wait to see that breakout and you plow in.
As production ramps up in Mexico, this miner offers investors an opportunity to profit from rising silver prices.
By Tyler Laundon, Small Cap Investor
The Fed's move in early December to essentially backstop the entire global financial system by becoming the lender of last resort is bullish for precious metals over the long term. My favorite way to play this trend is to purchase emerging gold and silver producers. Accordingly, my favorite stock for 2012 is Fortuna Silver Mines (FSM).
The second rescue since 2004 will be tough to pull off.
Hostess Brands, the maker of Twinkies, Ho-Hos and Ding Dongs, filed for bankruptcy protection for the second time since 2004 in the face of mounting debt, skyrocketing prices for ingredients and the adoption of more healthful lifestyles.
The company, which has about $860 million in debt, sought protection from creditors after failing to reach an agreement with workers on pensions and benefits, according to Reuters. The company has arranged for $75 million in debtor-in-possession (DIP) financing from a group of its existing first-lien lenders, led by Silver Point Capital.
The US presidential election, the growing euro crisis and higher consumer confidence will influence markets this year.
By Anne Brennan, The Fiscal Times
Investors are looking ahead for 2012, but many will be hoping history repeats itself. They're placing bets not on a repeat of 2011 but on U.S. presidential history.
Since the end of WWII, the second half of a president's term and the period leading up to a presidential election have tended to coincide with economic growth and better business conditions.
The company is bulletproof and will be for a while. But be careful how you invest in it.
If it sounds too good to be true, it is. That axiom seems to be especially true for stocks. Yet as much as I'd like to say Apple (AAPL) is too good to be true, it isn't.
Believe me. I looked for ways to find fault in Apple: flawed technology, unattainable expectations, weakening sales, anything. The company is bulletproof and will be for at least a couple of more years. That doesn't mean you should buy into Apple indiscriminately, though.
The division is coming off a year in which operating income dropped significantly.
This ETF tracking smaller mining companies will follow precious metals higher as currencies lose purchasing power.
By Gene Arensberg, Got Gold Report
With the smaller, less liquid and more speculative junior miners and explorers having been "clocked" by a fearful market, we think making space in one's portfolio for the Market Vectors Junior Gold Miners ETF (GDXJ) makes sense.
The biopharmaceutical company has a bright outlook for 2012.
By: Zacks Equity Research
Celgene Corp. (CELG) announced preliminary fourth-quarter earnings of $1.05 a share, excluding stock-based compensation and other items, beating its year-ago performance by 46%.
The biopharmaceutical company also posted some strong full-year numbers, with earnings (excluding stock-based compensation and other items) climbing 36% to $3.79 a share.
The new year may be tougher for the chip maker after a solid 2011.
Our price estimate for Intel stands at $29, implying a premium of about 15% to the market price.
Early indication eases fears of a Dendreon-like flop.
Regeneron Pharmaceuticals (REGN) needed to give investors an early signal that its new eye drug can keep pace in a competitive market. So the company blew away Wall Street's fourth-quarter sales estimates.
Shares of Regeneron jumped Tuesday morning after the company said its drug Eylea recorded as much as $25 million in sales in its first six weeks on the market. Analysts expected a little more than $3 million in sales.
MORE ON MSN MONEY
Copyright © 2014 Microsoft. All rights reserved.
Chains are ratcheting up their technology offerings in hopes of attracting younger travelers.
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.
[BRIEFING.COM] The S&P 500 (+0.1%) hovers right above its flat line with seven sectors sporting gains.
Market participants received just one economic data point today (June Pending Home Sales -1.1%), but the rest of the week will bring a full slate of data. Tomorrow, the Case-Shiller 20-city Index (Briefing.com consensus 10.0%) will be released at 9:00 ET, while the July Consumer Confidence report (consensus 85.6) will cross the wires at 10:00 ET.
As the week progresses, ... More
More Market News
|There’s a problem getting this information right now. Please try again later.|